TRIP10
Basic information
Region (hg38): 19:6737925-6751530
Previous symbols: [ "STOT" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIP10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 44 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 1 | 3 |
Variants in TRIP10
This is a list of pathogenic ClinVar variants found in the TRIP10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-6743035-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
19-6743037-G-C | not specified | Uncertain significance (Nov 13, 2023) | ||
19-6743053-G-A | not specified | Uncertain significance (Mar 14, 2023) | ||
19-6743058-C-T | not specified | Uncertain significance (Aug 30, 2022) | ||
19-6743212-C-G | not specified | Uncertain significance (Sep 17, 2021) | ||
19-6743213-G-A | not specified | Uncertain significance (May 31, 2023) | ||
19-6743219-A-G | not specified | Uncertain significance (Apr 15, 2024) | ||
19-6743236-G-T | not specified | Uncertain significance (Jan 24, 2024) | ||
19-6743237-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
19-6743245-C-G | not specified | Uncertain significance (Jul 28, 2021) | ||
19-6743500-C-G | not specified | Uncertain significance (Jun 04, 2024) | ||
19-6743554-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
19-6743567-A-G | not specified | Uncertain significance (Dec 07, 2021) | ||
19-6743732-A-G | not specified | Uncertain significance (Jan 26, 2022) | ||
19-6743781-G-A | not specified | Uncertain significance (May 24, 2024) | ||
19-6743834-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
19-6744568-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
19-6744608-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
19-6744663-G-A | not specified | Uncertain significance (Feb 08, 2023) | ||
19-6744809-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
19-6744816-T-C | not specified | Uncertain significance (Feb 07, 2023) | ||
19-6744854-G-A | not specified | Uncertain significance (Jun 23, 2023) | ||
19-6744891-C-T | not specified | Likely benign (Sep 14, 2022) | ||
19-6744921-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
19-6744953-C-T | not specified | Uncertain significance (Oct 26, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIP10 | protein_coding | protein_coding | ENST00000313285 | 14 | 13602 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000167 | 1.00 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.563 | 321 | 351 | 0.915 | 0.0000221 | 3604 |
Missense in Polyphen | 120 | 135.06 | 0.88848 | 1336 | ||
Synonymous | -0.406 | 138 | 132 | 1.04 | 0.00000819 | 1009 |
Loss of Function | 3.16 | 14 | 33.9 | 0.413 | 0.00000181 | 358 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000125 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for translocation of GLUT4 to the plasma membrane in response to insulin signaling (By similarity). Required to coordinate membrane tubulation with reorganization of the actin cytoskeleton during endocytosis. Binds to lipids such as phosphatidylinositol 4,5-bisphosphate and phosphatidylserine and promotes membrane invagination and the formation of tubules. Also promotes CDC42-induced actin polymerization by recruiting WASL/N- WASP which in turn activates the Arp2/3 complex. Actin polymerization may promote the fission of membrane tubules to form endocytic vesicles. Required for the formation of podosomes, actin-rich adhesion structures specific to monocyte-derived cells. May be required for the lysosomal retention of FASLG/FASL. {ECO:0000250, ECO:0000269|PubMed:11069762, ECO:0000269|PubMed:16318909, ECO:0000269|PubMed:16326391}.;
- Pathway
- Insulin signaling pathway - Homo sapiens (human);Angiopoietin Like Protein 8 Regulatory Pathway;Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;Rho GTPase cycle;Signaling by Rho GTPases;Clathrin-mediated endocytosis;Insulin Pathway;Insulin-mediated glucose transport
(Consensus)
Recessive Scores
- pRec
- 0.190
Intolerance Scores
- loftool
- 0.517
- rvis_EVS
- -0.86
- rvis_percentile_EVS
- 10.85
Haploinsufficiency Scores
- pHI
- 0.380
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trip10
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- endocytosis;cell communication;signal transduction;actin cytoskeleton organization;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;membrane organization
- Cellular component
- phagocytic cup;nucleoplasm;cytoplasm;lysosome;Golgi apparatus;cytosol;cytoskeleton;cell cortex;cell projection;intracellular membrane-bounded organelle;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- GTPase activator activity;protein binding;lipid binding;identical protein binding